Also for 2022, the Lifebility of Lions charity is proposing the Lifebility Award. The competition years has been aiming to find highly innovative ideas and projects that can help solve problems in our society. The watchword has always been “ethics”, a fundamental requirement for proposing projects that have an eye on the present and the future, and on the critical issues that hinder our society.
PlumeStars adhered to the Manifesto “Research and Innovation for the Future of Europe” proposed to reaffirm the key role of Research & Innovation for the future of Europe and its citizens.
PlumeStars, our Sme Innovative, is among the 101 Top Biotechnology Startups and Companies in Italy (2021) according to the site BestStartup.eu.
PlumeStars has the ambition to improve the patient quality of life offering patient-centric medicines.
Eride Quarta got the prestigious EUFEPS Women in Pharmaceutical Sciences Award 2021. The Women in Pharmaceutical Sciences (WIPS) initiative was established in 2017 by EUFEPS, European Federation of Pharmaceutical Sciences, with the aim of supporting the research of woman researchers, also facilitating international mobility and active participation in congresses.
The Medicine Maker is an authoritative medical-scientific magazine that constantly publishes articles and sector news promoting the medical-pharmaceutical scientific culture in the world.
On 22nd and 29th April 2021, PlumeStars organizes the Two day web course “Quality by Design in Pharmaceutical and Food Development. Theory and case studies”.
On 28 February 2021, the World Day of Rare Diseases was celebrated, a very significant celebration, which, since 2008, has contributed to keep the attention on rare diseases high and to “turn on the light” on them, as per the slogan chosen by UNIAMO (Federation of Associations of People with Rare Diseases of Italy).
X-HUB TOKYO’S INBOUND PROGRAM, sponsored by the Tokyo Metropolitan Government, is an accelerator program that provides opportunities for global startups in the field of FinTech, Mobility, and Life Science to enter Tokyo market.
Prof. Paolo Colombo, CEO of PlumeStars srl, has been invited to enter in the rExpert committee of the research project called AEROPERF. The project will take place in Liège, Belgium, subsidized by the Wallon Region. The Expert Committee included Prof. Nicolas Tsapis of Paris-Sud University and Marco Laackmann of Haro Hofliger.